Establishment of the method for predicting clinical effect of tocilizumab based on its serum concentration in rheumatoid arthritis patients
Not Applicable
Recruiting
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000041153
- Lead Sponsor
- Department of Hospital pharmacy Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients discontinuing tocilizumab. 2. Patients who are judged by physicians as inappropriate for study enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum tocilizumab concentration before dosing by intravenous or subcutaneous injection
- Secondary Outcome Measures
Name Time Method